• Je něco špatně v tomto záznamu ?

IPSC-Derived Corneal Endothelial-like Cells Act as an Appropriate Model System to Assess the Impact of SLC4A11 Variants on Pre-mRNA Splicing

K. Brejchova, L. Dudakova, P. Skalicka, R. Dobrovolny, P. Masek, M. Putzova, M. Moosajee, SJ. Tuft, AE. Davidson, P. Liskova,

. 2019 ; 60 (8) : 3084-3090. [pub] 20190701

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc19044653

Grantová podpora
Department of Health - United Kingdom
Wellcome Trust - United Kingdom

Purpose: To report molecular genetic findings in six probands with congenital hereditary endothelial dystrophy (CHED) variably associated with hearing loss (also known as Harboyan syndrome). Furthermore, we developed a cellular model to determine if disease-associated variants induce aberrant SLC4A11 pre-mRNA splicing. Methods: Direct sequencing of the entire SLC4A11 coding region was performed in five probands. In one individual, whole genome sequencing was undertaken. The effect of c.2240+5G>A on pre-mRNA splicing was evaluated in a corneal endothelial-like (CE-like) cell model expressing SLC4A11. CE-like cells were derived from autologous induced pluripotent stem cells (iPSCs) via neural crest cells exposed to B27, PDGF-BB, and DKK-2. Total RNA was extracted, and RT-PCR was performed followed by Sanger and a targeted next generation sequencing (NGS) approach to identify and quantify the relative abundance of alternatively spliced transcripts. Results: In total, 11 different mutations in SLC4A11 evaluated as pathogenic were identified; of these, c.1237G>A, c.2003T>C, c.1216+1G>A, and c.2240+5G>A were novel. The c.2240+5G>A variant was demonstrated to result in aberrant pre-mRNA splicing. A targeted NGS approach confirmed that the variant introduces a leaky cryptic splice donor site leading to the production of a transcript containing an insertion of six base pairs with the subsequent introduction of a premature stop codon (p.Thr747*). Furthermore, a subset of transcripts comprising full retention of intron 16 also were observed, leading to the same functionally null allele. Conclusions: This proof-of-concept study highlights the potential of using CE-like cells to investigate the pathogenic consequences of SLC4A11 disease-associated variants.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19044653
003      
CZ-PrNML
005      
20210610092408.0
007      
ta
008      
200109s2019 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1167/iovs.19-26930 $2 doi
035    __
$a (PubMed)31323090
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Brejchová, Kristýna $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic. $7 xx0101781
245    10
$a IPSC-Derived Corneal Endothelial-like Cells Act as an Appropriate Model System to Assess the Impact of SLC4A11 Variants on Pre-mRNA Splicing / $c K. Brejchova, L. Dudakova, P. Skalicka, R. Dobrovolny, P. Masek, M. Putzova, M. Moosajee, SJ. Tuft, AE. Davidson, P. Liskova,
520    9_
$a Purpose: To report molecular genetic findings in six probands with congenital hereditary endothelial dystrophy (CHED) variably associated with hearing loss (also known as Harboyan syndrome). Furthermore, we developed a cellular model to determine if disease-associated variants induce aberrant SLC4A11 pre-mRNA splicing. Methods: Direct sequencing of the entire SLC4A11 coding region was performed in five probands. In one individual, whole genome sequencing was undertaken. The effect of c.2240+5G>A on pre-mRNA splicing was evaluated in a corneal endothelial-like (CE-like) cell model expressing SLC4A11. CE-like cells were derived from autologous induced pluripotent stem cells (iPSCs) via neural crest cells exposed to B27, PDGF-BB, and DKK-2. Total RNA was extracted, and RT-PCR was performed followed by Sanger and a targeted next generation sequencing (NGS) approach to identify and quantify the relative abundance of alternatively spliced transcripts. Results: In total, 11 different mutations in SLC4A11 evaluated as pathogenic were identified; of these, c.1237G>A, c.2003T>C, c.1216+1G>A, and c.2240+5G>A were novel. The c.2240+5G>A variant was demonstrated to result in aberrant pre-mRNA splicing. A targeted NGS approach confirmed that the variant introduces a leaky cryptic splice donor site leading to the production of a transcript containing an insertion of six base pairs with the subsequent introduction of a premature stop codon (p.Thr747*). Furthermore, a subset of transcripts comprising full retention of intron 16 also were observed, leading to the same functionally null allele. Conclusions: This proof-of-concept study highlights the potential of using CE-like cells to investigate the pathogenic consequences of SLC4A11 disease-associated variants.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a proteiny přenášející anionty $x biosyntéza $x genetika $7 D027321
650    _2
$a antiportéry $x biosyntéza $x genetika $7 D017920
650    _2
$a buněčná diferenciace $7 D002454
650    _2
$a kultivované buňky $7 D002478
650    _2
$a dítě $7 D002648
650    _2
$a předškolní dítě $7 D002675
650    _2
$a dědičné dystrofie rohovky $x genetika $x metabolismus $x patologie $7 D003317
650    _2
$a rohovkový endotel $x metabolismus $x patologie $7 D004728
650    _2
$a ženské pohlaví $7 D005260
650    12
$a regulace genové exprese $7 D005786
650    _2
$a percepční nedoslýchavost $x genetika $x metabolismus $x patologie $7 D006319
650    _2
$a lidé $7 D006801
650    _2
$a indukované pluripotentní kmenové buňky $x cytologie $x metabolismus $7 D057026
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a rodokmen $7 D010375
650    _2
$a RNA $x genetika $7 D012313
650    _2
$a prekurzory RNA $7 D012322
650    _2
$a sestřih RNA $7 D012326
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Dudakova, Lubica $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic.
700    1_
$a Skalicka, Pavlina $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic. Department of Ophthalmology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
700    1_
$a Dobrovolny, Robert $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic.
700    1_
$a Masek, Petr $u Clinic of Ophthalmology, University Hospital Ostrava, Ostrava, Czech Republic. Department of Craniofacial Surgery, University of Ostrava, Ostrava, Czech Republic.
700    1_
$a Putzova, Martina $u Biopticka laborator s.r.o., Pilsen, Czech Republic.
700    1_
$a Moosajee, Mariya $u UCL Institute of Ophthalmology, London, United Kingdom. Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom. Great Ormond Street Hospital for Children, London, United Kingdom.
700    1_
$a Tuft, Stephen J $u UCL Institute of Ophthalmology, London, United Kingdom. Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom.
700    1_
$a Davidson, Alice E $u UCL Institute of Ophthalmology, London, United Kingdom.
700    1_
$a Liskova, Petra $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic. Department of Ophthalmology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic. UCL Institute of Ophthalmology, London, United Kingdom.
773    0_
$w MED00002404 $t Investigative ophthalmology & visual science $x 1552-5783 $g Roč. 60, č. 8 (2019), s. 3084-3090
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31323090 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200109 $b ABA008
991    __
$a 20210610092407 $b ABA008
999    __
$a ok $b bmc $g 1482922 $s 1083326
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 60 $c 8 $d 3084-3090 $e 20190701 $i 1552-5783 $m Investigative ophthalmology & visual science $n Invest Ophthalmol Vis Sci $x MED00002404
GRA    __
$p Department of Health $2 United Kingdom
GRA    __
$p Wellcome Trust $2 United Kingdom
LZP    __
$a Pubmed-20200109
Zpět

Najít záznam

Citační ukazatele

Možnosti archivace